New drugs for antibiotic resistant bacterial infections

治疗耐药细菌感染的新药

• 批准号: 213053
• 负责人: Dmitrienko Gary I
• 金额: $ 9.71万
• 依托单位: University of Waterloo (Ontario)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2010
• 资助国家: 加拿大
• 起止时间: 2010-09-01 至 2011-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=213053&lang=en
• 关键词: Anitbiotic Resistance; Antibioitcs; Carbapenemases; Carbapenems; Drug Discovery; Enzymology; Medicinal Chemistry; Microbiology; Organic Synthesis

Recent scientific discoveries at the University of Waterloo have led to the founding of a startup drug discovery company, Waterloo Pharmaceuticals Inc., in order to pursue practical solutions to serious health problems posed by bacterial infections th

滑铁卢大学最近的科学发现导致了一家初创药物发现公司滑铁卢制药公司的成立， 为了寻求由细菌感染引起的严重健康问题的实际解决方案，